Telesis Bio, Inc (TBIO): Growth-Adjusted Market Cap to Net Income
Telesis Bio, Inc. (TBIO) leverages a broad base of research centers to create automated DNA synthesis systems. The growth company undervaluation metric visualizes share price dynamics relative to earnings, where the 0.00 indicator expresses the state of the metric. The business is shielded from macroeconomic fluctuations by a sovereign development cycle, while management strives for leadership in the decentralized nucleic acid production segment.
Analytical breakdowns for Telesis Bio, Inc. (TBIO)
- current quotes and average value forecast:
- stock exchange capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- net income and valuation ratios data:
TBIO - Net Profit|Company Profit Forecast Telesis Bio, Inc.|TBIO - Price to Earnings Ratio|Price to Future Earnings Ratio Telesis Bio, Inc|TBIO - PEG Multiple|Enterprise Value to EBITDA Ratio Codex DNA|TBIO - Operating profit before deduction of amortization|Net earnings per share for the last four quarters Telesis Bio|TBIO - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months telesisbio.com|TBIO - Earnings growth in current year|Net earnings per share growth forecast for next year Telesis Bio, Inc.
General company analysis:TBIO, Telesis Bio Inc.
This indicator compares the P/E multiple with net income dynamics to determine the extent to which the stock price is justified by the pace of business expansion. Amid intense competition with laboratory equipment behemoths, the PEG filter for undervalued "rockets" helps identify a discrepancy between the market price of Telesis Bio, Inc. (TBIO) and its actual potential to grow its market share in the DNA synthesis segment.
Competitors of Telesis Bio, Inc.
TEM - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Qiagen Group QGEN|Growth-Adjusted Market Cap to Net Income Isis Pharmaceuticals (IONS)|Repligen Corporation - PEG Multiple|Growth-Adjusted Market Cap to Net Income aviditybiosciences.com RNA|CRISPR Therapeutics (CRSP) - Price/Earnings to Growth Ratio|WGS - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple RARE|BEAM: Growth-Adjusted Payback Ratio|PEG Multiple SRPT|Price/Earnings to Growth Ratio TWST (twistbioscience.com)|PEG Multiple TXG (10x Genomics)|Growth-Adjusted Market Cap to Net Income Intellia Therapeutics Inc (NTLA)|STOK - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate BioLife|WVE (Wave Life Sciences) - Price/Earnings to Growth Multiple|mazetx.com - Growth-Adjusted Payback Ratio|SION (Sionna Therapeutics) - PEG Multiple|Prime Medicine Inc (PRME) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Taysha (TSHA)|uniQure Pharma - Growth-Adjusted P/E Ratio|PEG Multiple MGTX (MeiraGTx Holdings plc)|RGNX - Price/Earnings to Growth Multiple|SLDB: Price/Earnings to Growth Multiple|Growth-Adjusted Market Cap to Net Income Ocugen Inc OCGN|PACB (Pacific Biosciences of California) - Price/Earnings to Growth Multiple|BNTC: Company Value to Earnings Growth Ratio|DSGN (Design Therapeutics) - PEG Multiple|Price/Earnings to Growth Ratio RCKT|PEG Multiple FDMT|Growth-Adjusted Market Cap to Net Income lexeotx.com|Price/Earnings to Growth Ratio Korro Bio KRRO|Editas Corp (EDIT) - Price to Earnings Adjusted for Growth Rate|Silence Therapeutics - PEG Multiple|PRQR (ProQR Therapeutics N.V.) - Growth-Adjusted P/E Ratio|codexis.com (CDXS) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio SGMO|NAUT (Nautilus Biotechnology, Inc.) - PEG Multiple|PEG Multiple Metagenomi Therapeutics|Price/Earnings to Growth Multiple DTIL (Precision BioSciences)|Company Value to Earnings Growth Ratio GBIO|PEG Multiple BOLD (Boundless Bio)|Exicure Inc. (XCUR) - Price to Earnings Adjusted for Growth Rate|IMNN - Price/Earnings to Growth Ratio|PHIO: Price/Earnings to Growth Ratio|MBIO: PEG Multiple|Price to Earnings Adjusted for Growth Rate TransCode Therapeutics, Inc. (RNAZ)|Price/Earnings to Growth Ratio Bionano Genomics Inc.|Applied DNA Sciences Inc (APDN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple BLUE|Growth-Adjusted Market Cap to Net Income immunoprecise.com|Price/Earnings to Growth Ratio Omega Therapeutics OMGA|Growth-Adjusted Market Cap to Net Income singulargenomics.com (OMIC)|RGLS: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio SYRS (Syros Pharmaceuticals Inc.)|TCON: PEG Multiple|UBX (Unity Biotechnology, Inc) - Price/Earnings to Growth Ratio
